Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance

NCT04892537 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04892537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04892537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Unknown status
Start date
May 21, 2021
Completion date
January 31, 2024
Enrollment
50 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

refractory angina